Heavy! The Beike Biology Academician (Expert) Workstation was approved for construction

On June 27, 2022, the Shenzhen Science and Technology Association issued a notice. In accordance with the relevant requirements of the “Shenzhen Academician (Expert) Workstation Construction Management and Funding Measures” (Shenzhen Regulations [2021] No. 4), after public declaration, qualification review and expert review, on-site inspection and social publicity, Agree to Shenzhen Beike Biotechnology Co., Ltd. to establish the Shenzhen Academician (Expert) Workstation.

It is reported that Beike Biotech has introduced field surgery expert Wang Zhengguo, an academician of the Chinese Academy of EngineeringServes as a cooperating academician of the Academician (Expert) Workstation, and is committed to the research of stem cells in regenerative medicine and related disease treatment.

Academician Wang Zhengguo is the main founder of the research on impact trauma, trauma ballistics, and transportation medicine in my country. He has been committed to basic theoretical and applied basic research on combat trauma for more than 40 years. He has achieved a number of internationally advanced and even leading major scientific research results in the basic research on impact injury, trauma ballistics, and impact injury (traffic medicine). He has made outstanding contributions to the development of combat trauma medicine in my country and enjoys a high reputation internationally. He has published more than 210 papers as the first author, has edited or edited more than 20 monographs, and participated in the editing of more than 10 books. He has won 1 first prize, 1 second prize, and 4 third prizes of the National Science and Technology Progress Award, 1 third prize of the National Invention Award, and 4 first prizes and 16 second prizes of the Military Science and Technology Progress Award. The “Basic Research on Early Systemic Damage and Tissue Repair in Severe Trauma” organized and led by him was designated by the Ministry of Science and Technology as the second batch of national key basic research and development planning projects, thus becoming the first chief scientist of the military’s “973” project.

In the future, Beike Biotech will continue to focus on key scientific issues and cutting-edge technologies in the field of stem cells and regenerative medicine, and is committed to promoting the in-depth integration of industry, academia and research. baseline;”>Work with the expert team of Academician Wang Zhengguo to carry out project cooperation in various aspects such as the research and development of empowering MSCs for personalized precision treatment, the development and application of biomaterials loaded with stem cells that can be used for clinical applications, the application research of iPSCs in clinical indications, and the formulation of standardized protocols for stem cells to treat different clinical indications.

Innovation drives development and moves towards a technologically powerful country. Currently, the state emphasizes the important position of enterprises in technological innovation decision-making, R&D investment, scientific research organization and achievement transformation, and promotes the integration of industry, academia and research to achieve high-quality development. Beike Biotech Academician (Expert) Workstation will, under the leadership of Academician Wang Zhengguo, conduct in-depth research in the field of tissue damage repair and regenerative medicine, improve the company’s overall scientific research strength, promote the transformation of scientific research results, and strive to make Beike Biotech a leading company in promoting the clinical transformation of biotherapeutic technologies, and make unremitting efforts to improve human health!